InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,725.20
(
1.50%
)
Dow Jones
41,914.75
(
0.00%
)
Brent Oil
71.24
(
-2.67%
)
Bitcoin
64,378.71
(
1.97%
)
Post# of 253228
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

midastouch017

Send PM Follow Ignore
Followers 144
Posts 27709
Boards Moderated 3
Alias Born 02/07/2004

midastouch017

Re: None

Monday, 09/18/2017 8:37:15 AM

Monday, September 18, 2017 8:37:15 AM

Post# of 253228
PSTI U.S. FDA Grants Fast Track Designation to Pluristem's PLX-PAD for the Treatment of Critical Limb Ischemia (CLI)

GlobeNewswire•September 18, 2017
Pluristem’s Ongoing Phase III CLI trial has been selected for accelerated approval pathways in both the U.S. and Europe
Fast Track Designation allows for expedited review of drugs to treat serious conditions with unmet medical need.

https://finance.yahoo.com/news/u-fda-grants-fast-track-110000519.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up